Unknown

Dataset Information

0

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.


ABSTRACT: Toll-like receptor (TLR) agonists are promising adjuvants for immune therapy of cancer, but their potential efficacy as single or combinatorial agents has yet to be fully evaluated. Here, we report that among all TLR agonists tested, dendritic cells (DC) stimulated with the TLR3 agonist polyI:C displayed the strongest activity in stimulating proinflammatory responses and the production of melanoma antigen-specific CD8(+) T cells. Simultaneous treatment with TLR7/8 agonists further improved these responses, but the inclusion of bacterial lipopolysaccharide (LPS), a TLR4 agonist, suppressed proinflammatory cytokine production. This inhibition was contingent upon rapid induction of the suppressive cytokine interleukin (IL)-10 by LPS, leading to dysregulated immune responses and it could be reversed by signal transducers and activators of transcription 3 knockdown, p38 blockade or antibodies to IL-10 and its receptor. Our findings show how certain TLR agonist combinations can enhance or limit DC responses associated with antitumor immunity, through their relative ability to induce IL-10 pathways that are immune suppressive.

SUBMITTER: Bogunovic D 

PROVIDER: S-EPMC3156386 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.

Bogunovic Dusan D   Manches Olivier O   Godefroy Emmanuelle E   Yewdall Alice A   Gallois Anne A   Salazar Andres M AM   Marie Isabelle I   Levy David E DE   Bhardwaj Nina N  

Cancer research 20110705 16


Toll-like receptor (TLR) agonists are promising adjuvants for immune therapy of cancer, but their potential efficacy as single or combinatorial agents has yet to be fully evaluated. Here, we report that among all TLR agonists tested, dendritic cells (DC) stimulated with the TLR3 agonist polyI:C displayed the strongest activity in stimulating proinflammatory responses and the production of melanoma antigen-specific CD8(+) T cells. Simultaneous treatment with TLR7/8 agonists further improved these  ...[more]

Similar Datasets

| S-EPMC6287797 | biostudies-other
| S-EPMC6555426 | biostudies-literature
| S-EPMC6129595 | biostudies-literature
| S-EPMC10964083 | biostudies-literature
| S-EPMC5356831 | biostudies-literature
2016-07-27 | E-GEOD-84849 | biostudies-arrayexpress
| S-EPMC5321715 | biostudies-literature
| S-EPMC4210310 | biostudies-literature
| S-EPMC8446094 | biostudies-literature
| S-EPMC2493000 | biostudies-other